Cardurion Pharmaceuticals’ $300 Million Investment

Mintz advised Cardurion Pharmaceuticals on the deal.Cardurion Pharmaceuticals, Inc. (Cardurion), a clinical-stage biotechnology company, announced a private investment of up to $300 million from Bain Capital Life…